Daniel Liptak
Follow
Get notifications in MyBN when activity occurs.
Daniel Liptak
Non-Executive Director / Absolute Equity Performance Fund
Daniel Liptak has over 26 years of experience across investment banking and funds management, encompassing mergers and acquisitions (M&A), capital raising, equity markets, derivatives, and risk management, wealth management, and financial advice.
He has provided focused advice to many investors and their advisors concerning all asset types including fixed income, listed and unlisted equities, private equity, venture capital, and derivatives.
Mr Liptak has also provided retail financial research and presented to retail financial advisors at professional development conferences.
He has provided focused advice to many investors and their advisors concerning all asset types including fixed income, listed and unlisted equities, private equity, venture capital, and derivatives.
Mr Liptak has also provided retail financial research and presented to retail financial advisors at professional development conferences.
Lists and Charts
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 683rd |  | Absolute Equity Performance Fund | $21.6m |
| 794th |  | Clarity Pharmaceuticals | $9.8m |
| 795th | | Silex Systems | $9.7m |
| 797th | | Bluglass | $9.5m |
| 799th | | WAM Active | $9.3m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, Absolute Equity Performance Fund | 30 Jan 2022 |
